Wei Peng and colleagues discovered that the expression levels of AIFM2 and IGF2BP1 are significantly elevated in HCC tissue and are associated with poor patient survival rates, with a positive correlation observed between IGF2BP1 and AIFM2. This evidence concerns the gene AIFM2 and hepatocellular carcinoma.